Difficulty: Medium
Average Score: 62%
Practice
A 79-year-old man with Alzheimer's disease is found to have significant elevation of liver function tests on routine follow-up examination. Which of the following medications should be maintained at current doses in this patient?
Correct answer
C
Rationale
In this scenario, the correct medication to be maintained at the current dose for the 79-year-old man with Alzheimer's disease and elevated liver function tests is Rivastigmine (Option C).
Rivastigmine is a cholinesterase inhibitor commonly used in Alzheimer's disease. Unlike other cholinesterase inhibitors like Donepezil (Option A), Galantamine (Option B), and Tacrine (Option D), Rivastigmine has a lower risk of hepatotoxicity and is less likely to exacerbate liver function abnormalities. This is due to its metabolism pathway, which involves minimal hepatic processing compared to the other medications listed.
For educational context, it is crucial to understand the pharmacokinetics and potential adverse effects of medications used in Alzheimer's disease treatment. Considering a patient's comorbidities, such as liver dysfunction in this case, is vital in selecting appropriate medications to avoid further harm or complications. Pharmacovigilance and individualized treatment plans are essential in managing elderly patients with complex medical conditions like Alzheimer's disease and liver function abnormalities.
Rivastigmine is a cholinesterase inhibitor commonly used in Alzheimer's disease. Unlike other cholinesterase inhibitors like Donepezil (Option A), Galantamine (Option B), and Tacrine (Option D), Rivastigmine has a lower risk of hepatotoxicity and is less likely to exacerbate liver function abnormalities. This is due to its metabolism pathway, which involves minimal hepatic processing compared to the other medications listed.
For educational context, it is crucial to understand the pharmacokinetics and potential adverse effects of medications used in Alzheimer's disease treatment. Considering a patient's comorbidities, such as liver dysfunction in this case, is vital in selecting appropriate medications to avoid further harm or complications. Pharmacovigilance and individualized treatment plans are essential in managing elderly patients with complex medical conditions like Alzheimer's disease and liver function abnormalities.